Taurine Intake, Plasma Taurine Concentration, and Dementia Risk: Findings From the Malmö Diet and Cancer Study

Area of Science:

• Neuroscience
• Nutritional Science
• Epidemiology

Background:

• Preclinical research suggests taurine has neuroprotective properties.
• The role of taurine in human dementia risk is not well understood.

Purpose of the Study:

• To investigate the association between mid-life taurine intake and plasma concentrations with late-life dementia risk.
• To examine the relationship with all-cause dementia, Alzheimer's disease (AD), and vascular dementia (VaD).

Main Methods:

• Prospective cohort study of 27,786 participants from the Malmö Diet and Cancer Study.
• Dietary taurine intake assessed via diet history; plasma taurine measured in a subset.
• Dementia diagnoses ascertained via national registers and validated; Cox proportional hazards models used.

Main Results:

• No significant associations were observed between dietary or plasma taurine and the risk of all-cause dementia, AD, or VaD.
• Plasma taurine weakly correlated with dietary intake, suggesting significant endogenous synthesis.
• Findings do not support a protective role for taurine intake against dementia in humans.

Conclusions:

• Dietary taurine intake and circulating taurine concentrations are not associated with reduced dementia risk in the general population.
• Further research may explore taurine's effects in specific conditions or with supplementation.
• Endogenous taurine production appears more significant than dietary intake for circulating levels.